O. Barthelemy

发表

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis

G. Montalescot, M. Kerneis, J. Collet, 2014, BMJ.

Bleeding complications in primary percutaneous coronary intervention of ST‐elevation myocardial infarction in a radial center

G. Montalescot, D. Costagliola, J. Collet, 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Optimal Use of Thienopyridines in Non-ST-Elevation Acute Coronary Syndrome Following CURRENT-OASIS 7

G. Montalescot, J. Collet, J. Silvain, 2011, Circulation. Cardiovascular interventions.

Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.

E. Vicaut, J. Dallongeville, G. Montalescot, 2009, The American journal of cardiology.

PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock

H. Thiele, S. Windecker, M. Noc, 2017, The New England journal of medicine.

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study.

E. Vicaut, G. Montalescot, J. Collet, 2013, International journal of cardiology.

Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention

G. Montalescot, D. Costagliola, J. Collet, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients.

D. Le Guludec, F. Rouzet, S. Jacqueminet, 2010, Diabetes & metabolism.

Cerebral Embolism: A Silent Iatrogenic Complication of TAVR That Needs Voiced Consideration.

G. Montalescot, J. Collet, O. Barthelemy, 2016, Journal of the American College of Cardiology.

Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients.

A. Pavie, P. Cluzel, G. Helft, 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy Introduction

Deepak L. Bhatt, F. Rutten, B. Lewis, 2021 .

Coronary revascularization in the diabetic patient.

G. Montalescot, M. Kerneis, J. Collet, 2014, Circulation.

Stress myocardial scintigraphy and dobutamine echocardiography in the detection of coronary disease in asymptomatic patients with type 2 diabetes.

C. Maunoury, D. Dubois-Laforgue, J. Timsit, 2005, Diabetes & metabolism.

Clinical Outcomes According to ECG Presentations in Infarct-Related Cardiogenic Shock in the Culprit Lesion Only PCI vs Multivessel PCI in Cardiogenic Shock Trial

J. J. Piek, E. Vicaut, H. Thiele, 2022, Chest.

Long-term follow-up of patients with sirolimus-eluting stents for treatment of bare-metal in-stent restenosis.

G. Helft, G. Montalescot, J. Collet, 2010, International journal of cardiology.

Should Hemoglobin Drop Be Added to Bleeding Classifications in ACS?

G. Montalescot, G. Cayla, O. Barthelemy, 2021, Journal of the American College of Cardiology.

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay

G. Montalescot, M. Kerneis, J. Collet, 2013, Thrombosis and Haemostasis.

Slow response to clopidogrel predicts low response.

G. Montalescot, J. Collet, J. Silvain, 2010, Journal of the American College of Cardiology.

Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical Trial.

H. Thiele, K. Huber, L. Maier, 2020, JAMA cardiology.

Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years.

G. Helft, G. Montalescot, J. Collet, 2008, Archives of cardiovascular diseases.

Influence of peripheral arterial occlusive disease on the Neuropad® test performance in patients with diabetes

A. Hartemann, C. Aubert, O. Bourron, 2013, Diabetic medicine : a journal of the British Diabetic Association.

One‐Year Outcomes after PCI Strategies in Cardiogenic Shock

H. Thiele, S. Windecker, M. Noc, 2018, The New England journal of medicine.

Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.

E. Vicaut, H. Thiele, G. Montalescot, 2021, Journal of the American College of Cardiology.

Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.

H. Thiele, G. Montalescot, M. Kerneis, 2020, JACC. Cardiovascular interventions.

Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trial.

H. Thiele, S. Windecker, J. Piek, 2020, American heart journal.

Impact of Chronic Total Occlusion and Revascularization Strategy in Patients with Infarct-Related Cardiogenic Shock A Subanalysis of the CULPRIT-SHOCK trial.

H. Thiele, G. Montalescot, S. Schneider, 2020, American heart journal.

S. Rouanet, Uwe Zeymer, O. Barthelemy, 2021, Journal of the American College of Cardiology.

Investigator Versus Core Laboratory Evaluation of Coronary Flow and Related Mortality in the CULPRIT-SHOCK Trial.

E. Vicaut, H. Thiele, G. Montalescot, 2019, Circulation. Cardiovascular interventions.

Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.

G. Montalescot, M. Kerneis, J. Collet, 2015, Archives of cardiovascular diseases.

Long-Term Mortality and Early€Valve€Dysfunction According€to€Anticoagulation Use

E. Vicaut, P. Leprince, B. Iung, 2019 .

Low level exercise echocardiography helps diagnose early stage heart failure with preserved ejection fraction: a study of echocardiography versus catheterization

M. Komajda, G. Helft, A. Mallet, 2017, Clinical Research in Cardiology.

High doses of clopidogrel to overcome genetic resistance: the randomized crossover CLOVIS-2 (Clopidogrel and Response Variability Investigation Study 2).

G. Montalescot, J. Hulot, J. Collet, 2011, JACC. Cardiovascular interventions.

Incidence of, risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation.

E. Vicaut, P. Leprince, G. Montalescot, 2019, Archives of cardiovascular diseases.

Percutaneous coronary intervention in anticoagulated patients via radial artery access

A. Zaman, G. Helft, F. Beygui, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Would Anyone Dare Abandon Repositioning of Self-Expanding TAVR?

J. Collet, O. Barthelemy, 2020, JACC. Cardiovascular interventions.

Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.

G. Montalescot, M. Kerneis, J. Collet, 2019, Archives of cardiovascular diseases.

Moving Toward Eradication of Stent Thrombosis.

G. Montalescot, O. Barthelemy, 2016, Journal of the American College of Cardiology.

Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.

E. Vicaut, K. Huber, G. Montalescot, 2013, The American journal of cardiology.

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Deepak L. Bhatt, F. Rutten, B. Lewis, 2020, European heart journal.

Cusp-Overlapping Projections in TAVR

J. Collet, O. Barthelemy, Redheuil, 2022, JACC: Cardiovascular Interventions.

Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients scheduled for heart valve surgery.

P. Cluzel, G. Helft, C. Le Feuvre, 2012, Archives of cardiovascular diseases.

Prevention and treatment of premature ischaemic heart disease with European Society of Cardiology Guidelines

G. Montalescot, M. Kerneis, J. Collet, 2022, Heart.

Questions and answers on workup diagnosis and risk stratification: a companion document of the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

F. Rutten, H. Thiele, A. Kastrati, 2020, European heart journal.

Enoxaparin anticoagulation monitoring in the catheterization laboratory using a new bedside test.

G. Montalescot, D. Costagliola, J. Collet, 2010, Journal of the American College of Cardiology.

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Deepak L. Bhatt, F. Rutten, B. Lewis, 2021, Revista espanola de cardiologia.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Can we override clopidogrel resistance?

G. Montalescot, J. Hulot, J. Collet, 2009, Circulation.

On- Versus Off-Hours Presentation and Mortality of ST-Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention.

G. Helft, G. Montalescot, M. Kerneis, 2019, JACC. Cardiovascular interventions.

Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE Study

P. Leprince, G. Montalescot, J. Amour, 2015, Circulation. Cardiovascular interventions.

Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.

G. Helft, G. Montalescot, M. Kerneis, 2015, Archives of cardiovascular diseases.

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Luis Pedro Coelho, P. Bork, F. Bäckhed, 2020, Nature Communications.

Bedside monitoring to adjust antiplatelet therapy for coronary stenting.

E. Vicaut, G. Montalescot, M. Kerneis, 2012, The New England journal of medicine.

High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study.

G. Montalescot, J. Hulot, M. Kerneis, 2012, European heart journal.

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Luis Pedro Coelho, P. Bork, V. Tremaroli, 2020, Nature.

Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis.

S. Scott, G. Montalescot, J. Hulot, 2011, JAMA.

Long-Term Evolution of Premature Coronary Artery Disease.

E. Vicaut, G. Montalescot, J. Hulot, 2019, Journal of the American College of Cardiology.

Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia.

G. Montalescot, J. Collet, J. Silvain, 2013, International journal of cardiology.

Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

G. Montalescot, J. Collet, J. Silvain, 2012, JAMA.

Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial.

E. Vicaut, J. Dubois-Randé, G. Montalescot, 2009, JAMA.

FXIII-A Leu34 genetic variant in premature coronary artery disease: A genotype – phenotype case control study

J. Weisel, G. Montalescot, J. Hulot, 2011, Thrombosis and Haemostasis.

Silent myocardial ischemia screening in patients with diabetes mellitus.

J. Timsit, C. Le Feuvre, O. Barthelemy, 2007, Arquivos brasileiros de endocrinologia e metabologia.

Impact of red blood cell transfusion on platelet activation and aggregation in healthy volunteers: results of the TRANSFUSION study.

G. Montalescot, J. Collet, D. Brieger, 2010, European heart journal.

Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention

G. Helft, G. Montalescot, M. Kerneis, 2017, Heart.

Composition of coronary thrombus in acute myocardial infarction.

J. Weisel, G. Montalescot, J. Collet, 2011, Journal of the American College of Cardiology.

Impact of transfer time on mortality in acute coronary syndrome with ST-segment elevation treated by angioplasty.

G. Montalescot, J. Collet, J. Silvain, 2012, Archives of cardiovascular diseases.

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.

G. Montalescot, J. Hulot, J. Collet, 2010, Journal of the American College of Cardiology.

New P2Y12 inhibitors versus clopidogrel in percutaneous coronary intervention: a meta-analysis.

G. Montalescot, J. Collet, D. Brieger, 2010, Journal of the American College of Cardiology.

High Plasma Aldosterone Levels on Admission Are Associated With Death in Patients Presenting With Acute ST-Elevation Myocardial Infarction

G. Montalescot, J. Collet, F. Beygui, 2006, Circulation.

Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study

E. Vicaut, G. Montalescot, J. Collet, 2011, Heart.

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome

G. Montalescot, Junxiang Luo, J. Collet, 2009, Thrombosis and Haemostasis.

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis

E. Vicaut, K. Huber, G. Montalescot, 2012, BMJ : British Medical Journal.

Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors.

Deepak L. Bhatt, G. Montalescot, J. Collet, 2013, International journal of cardiology.

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Coronary Stent Revascularization: A Landmark Analysis of the ARCTIC Study

E. Vicaut, G. Montalescot, M. Kerneis, 2014, Circulation.

Syndromes : A Randomized Clinical Trial Immediate vs Delayed Intervention for Acute Coronary

J. Collet, J. Silvain, F. Beygui, 2009 .

One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.

G. Helft, G. Montalescot, J. Collet, 2011, Archives of cardiovascular diseases.

Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study.

E. Vicaut, G. Montalescot, J. Collet, 2018, International journal of cardiology.

Clinical Outcome of First‐ vs Second‐Generation DES According to DAPT Duration: Results of ARCTIC‐Generation

E. Vicaut, E. Belle, G. Montalescot, 2016, Clinical cardiology.

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial

E. Vicaut, E. Belle, G. Montalescot, 2014, The Lancet.

Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial

E. Vicaut, G. Rioufol, G. Lemesle, 2020, The Lancet.

Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study

E. Vicaut, E. Belle, G. Montalescot, 2015, European Journal of Clinical Pharmacology.

Periprocedural myocardial infarction and injury in elective coronary stenting

G. Helft, G. Montalescot, M. Kerneis, 2018, European heart journal.

Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y12 inhibition: Results of the randomized DOSAPI study

G. Montalescot, J. Hulot, M. Kerneis, 2014, European Journal of Clinical Pharmacology.

Background—Individualizing antiplatelet therapy after platelet function testing did not improve outcome after coronary stenting in the Assessment by a Double Randomization of a Conventional Antiplatelet Strategy Versus a Monitoring- Guided Strategy for Drug-Eluting Stent Implantation and of Treatmen

E. Vicaut, E. Belle, G. Montalescot, 2014 .

Switching acute coronary syndrome patients from prasugrel to clopidogrel.

G. Montalescot, M. Kerneis, J. Collet, 2013, JACC. Cardiovascular interventions.

Long-Term Mortality and Early Valve Dysfunction According to Anticoagulation Use: The FRANCE TAVI Registry.

E. Vicaut, P. Leprince, B. Iung, 2019, Journal of the American College of Cardiology.

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians

A. Zaman, G. Helft, A. Segev, 2016, Heart.

G. Helft, G. Montalescot, M. Kerneis, 2015, Archives of cardiovascular diseases.

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Luis Pedro Coelho, P. Bork, V. Tremaroli, 2020, Nature.

Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE study

E. Vicaut, E. Belle, G. Montalescot, 2015, European Journal of Clinical Pharmacology.

Impact of negative inotropic drugs on accuracy of diastolic stress echocardiography for evaluation of left ventricular filling pressure

G. Helft, J. Hulot, C. Funck-Brentano, 2017, Scientific Reports.

Author Correction: Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Luis Pedro Coelho, P. Bork, F. Bäckhed, 2020, Nature Communications.

Fractional Flow Reserve to Guide Treatment of Patients With Multivessel Coronary Artery Disease.

P. Lesault, B. Harbaoui, N. Mewton, 2021, Journal of the American College of Cardiology.

G. Helft, G. Montalescot, M. Kerneis, 2015 .

Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P 450 2 C 19 * 2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration

G. Montalescot, J. Hulot, J. Collet, 2022 .

Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention

E. Vicaut, K. Huber, G. Montalescot, 2017, Angiology.

Effect of oral anticoagulation on clinical outcomes and haemodynamic variables after successful transcatheter aortic valve implantation.

E. Vicaut, P. Leprince, G. Montalescot, 2020, Archives of cardiovascular diseases.

Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome

E. Vicaut, G. Montalescot, J. Hulot, 2015, Thrombosis and Haemostasis.

Prasugrel but not high dose clopidogrel overcomes the lansoprazole neutralizing effect of P2Y12 inhibition: Results of the randomized DOSAPI study

G. Montalescot, J. Hulot, M. Kerneis, 2014, European Journal of Clinical Pharmacology.

Myocardial ischemia: a silent epidemic in Type 2 diabetes patients.

S. Jacqueminet, C. Le Feuvre, O. Barthelemy, 2011, Future cardiology.

Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes.

D. Le Guludec, F. Rouzet, S. Jacqueminet, 2008, Archives of cardiovascular diseases.

Left atrial high-grade undifferentiated pleomorphic sarcoma protruding through the mitral valve.

P. Leprince, G. Montalescot, R. Isnard, 2014, Annals of Thoracic Surgery.

Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction in Nonagenarians: A Multicenter Study

A. Zaman, G. Helft, A. Segev, 2015, Journal of the American Geriatrics Society.